Form 4: Precigen COO Rutul R. Shah Executes RSU Vesting

Precigen Chief Operating Officer Rutul R. Shah acquired 90,000 shares of common stock through the vesting of restricted stock units.

Summary

• Rutul R. Shah, Chief Operating Officer of Precigen, Inc., acquired 90,000 shares of common stock on May 23, 2026.
• The acquisition resulted from the vesting of restricted stock units (RSUs) granted on June 26, 2025.
• Following this transaction, the reporting person holds a total of 540,454 shares of common stock.
• The transaction represents 50% of the original RSU grant, with the remainder scheduled to vest in equal quarterly installments over the next three years.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event related to executive compensation, having no direct impact on the company's operational or financial trajectory.

Positives

• The transaction reflects the ongoing vesting of equity-based compensation, aligning the executive's interests with long-term shareholder value.

Negatives

• None identified.

Risks

• Future vesting of remaining RSUs is subject to continued employment and company performance conditions.

Future Outlook

The remaining 50% of the June 26, 2025 RSU grant will vest in equal quarterly installments over the three years following May 23, 2026.

Industry Context

StockSavvy.ai notes that executive equity vesting is a standard corporate governance practice in the biotechnology sector, serving as a retention mechanism for key leadership personnel.

Comparison to Industry Standards

• The vesting schedule and equity compensation structure are consistent with standard practices for C-suite executives in mid-cap biotechnology firms.
• The reporting of this transaction complies with SEC Section 16(a) requirements for timely disclosure of insider holdings.

Stakeholder Impact

• Increased share ownership by the COO may be viewed positively by shareholders as a sign of commitment to the company.

Next Steps

• Continued quarterly vesting of the remaining RSU balance over the next three years.

Key Dates

Keywords

Precigen, PGEN, Insider Trading, Form 4, Equity Compensation, Rutul R. Shah